Cited by 723Alzheimer's disease research and treatmentsHeat shock proteins researchUbiquitin and proteasome pathways

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Petrucelli, L.·2004·Human Molecular Genetics

Open this paper in CoChat — free account

Abstract

Molecular chaperones, ubiquitin ligases and proteasome impairment have been implicated in several neurodegenerative diseases, including Alzheimer's and Parkinson's disease, which are characterized by accumulation of abnormal protein aggregates (e.g. tau and alpha-synuclein respectively). Here we report that CHIP, an ubiquitin ligase that interacts directly with Hsp70/90, induces ubiquitination of the microtubule associated protein, tau. CHIP also increases tau aggregation. Consistent with this observation, diverse of tau lesions in human postmortem tissue were found to be immunopositive for CHIP. Conversely, induction of Hsp70 through treatment with either geldanamycin or heat shock factor 1 leads to a decrease in tau steady-state levels and a selective reduction in detergent insoluble tau. Furthermore, 30-month-old mice overexpressing inducible Hsp70 show a significant reduction in tau levels. Together these data demonstrate that the Hsp70/CHIP chaperone system plays an important role in the regulation of tau turnover and the selective elimination of abnormal tau species. Hsp70/CHIP may therefore play an important role in the pathogenesis of tauopathies and also represents a potential therapeutic target.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddh083

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371
Repression of Heat Shock Transcription Factor HSF1 Activation by HSP90 (HSP90 Complex) that Forms a Stress-Sensitive Complex with HSF1
Zou, J., Guo, Y., Guettouche, T., Smith, D. F., & Voellmy, R. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81588-3 · Cited by 1,232
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134

Show all 41 references

Sorted by citations

Items 301–400 of 719

Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson’s and Alzheimer’s Diseases
Boyko, A., Troyanova, N. I., Kovalenko, E. I., & Sapozhnikov, A. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122633 · Cited by 54
Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model
Klein, R. L., Dayton, R. D., Henderson, K. M., & Petrucelli, L. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.001 · Cited by 50
Self-citation
Alleviating Neurodegeneration by an Anticancer Agent
Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Tanaka, F., & Sobue, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1377.012 · Cited by 50
Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core
Vacchi, E., Kaelin‐Lang, A., & Melli, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145030 · Cited by 51
Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer
Papin, S., & Paganetti, P. (2020) · Brain Sciences · doi:10.3390/brainsci10110862 · Cited by 45
Hsp70 ATPase Modulators as Therapeutics for Alzheimer's and other Neurodegenerative Diseases.
Jinwal, U. K., Koren, J., O’Leary, J. C., Jones, J. R., Abisambra, J. F., & Dickey, C. A. (2010) · PubMed · Cited by 48
Tau is not normally degraded by the proteasome
Feuillette, S., Blard, O., Lecourtois, M., Frébourg, T., Campion, D., & Dumanchin‐Njock, C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20414 · Cited by 48
Molecular chaperones as regulators of cell death
Hishiya, A., & Takayama, S.-I. J. (2008) · Oncogene · doi:10.1038/onc.2008.314 · Cited by 48
The Effects of the Polyglutamine Repeat Protein Ataxin-1 on the UbL-UBA Protein A1Up
Riley, B. E., Xu, Y., Zoghbi, H. Y., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406284200 · Cited by 48
Dealing with Misfolded Proteins: Examining the Neuroprotective Role of Molecular Chaperones in Neurodegeneration
Ali, Y., Kitay, B. M., & Zhai, R. G. (2010) · Molecules · doi:10.3390/molecules15106859 · Cited by 49
Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease
Zhu, H., Xue, X., Wang, E., Wallack, M., Na, H., Hooker, J. M., Kowall, N. W., Tao, Q., Stein, T. D., Wolozin, B. L., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.030 · Cited by 48
Progressive Supranuclear Palsy and Corticobasal Degeneration
Dickson, D. W., Hauw, J. J., Agid, Y., & Litvan, I. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch15 · Cited by 48
G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain
Nguyen, A. P. T., Daniel, G., Valdés, P., Islam, M. S., Schneider, B. L., & Moore, D. J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx389 · Cited by 46
Lithium down-regulates tau in cultured cortical neurons: A possible mechanism of neuroprotection
Rametti‐Lacroux, A., Esclaire, F., Yardin, C., Cogné, N., & Terro, F. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.01.034 · Cited by 45
A single amino acid substitution differentiates Hsp70-dependent effects on α-synuclein degradation and toxicity
Klucken, J., Shin, Y., Hyman, B. T., & McLean, P. J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.037 · Cited by 44
Generation of Tau Aggregates and Clearance by Autophagy in an Inducible Cell Model of Tauopathy
Wang, Y., Krüger, U., Mandelkow, E., & Mandelkow�, E. (2010) · Neurodegenerative Diseases · doi:10.1159/000285516 · Cited by 43
Defining an Embedded Code for Protein Ubiquitination
Jadhav, T., & Wooten, M. W. (2009) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000091 · Cited by 47
Lithium Treatment of APPSwDI/NOS2−/− Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype
Sudduth, T. L., Wilson, J. G., Everhart, A. L., Colton, C. A., & Wilcock, D. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031993 · Cited by 44
All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration
Argueti-Ostrovsky, S., Alfahel, L., Kahn, J., & Israelson, A. (2021) · Cells · doi:10.3390/cells10092438 · Cited by 46
Ubiquitination of Alzheimer's-related tau protein affects liquid-liquid phase separation in a site- and cofactor-dependent manner
Parolini, F., Tira, R., Barracchia, C. G., Munari, F., Capaldi, S., D’Onofrio, M., & Assfalg, M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.191 · Cited by 43
A Protein Silencing Switch by Ligand-induced Proteasome-targeting Intrabodies
Melchionna, T., & Cattaneo, A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.053 · Cited by 43
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Wang, L., Banesh, S., Kumar, R., Schedin‐Weiss, S., Tjernberg, L. O., & Winblad, B. G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70048 · Cited by 47
Female Hippocampus Vulnerability to Environmental Stress, a Precipitating Factor in Tau Aggregation Pathology
Sotiropoulos, I., Silva, J. M., Kimura, T., Rodrigues, A. J., Costa, P., Almeida, O. F. X., Sousa, N., & Takashima, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140693 · Cited by 40
The double faced role of copper in Aβ homeostasis: A survey on the interrelationship between metal dyshomeostasis, UPS functioning and autophagy in neurodegeneration
Grasso, G., Santoro, A. M., Lanza, V., Sbardella, D., Tundo, G. R., Ciaccio, C., Marini, S., Coletta, M., & Milardi, D. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.06.004 · Cited by 42
To target Tau pathologies, we must embrace and reconstruct their complexities
Limorenko, G., & Lashuel, H. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105536 · Cited by 41
Carboxyl terminus of Hsp70‐interacting protein (CHIP) is required to modulate cardiac hypertrophy and attenuate autophagy during exercise
Willis, M. S., Min, J., Wang, S., McDonough, H., Lockyer, P. P., Wadosky, K. M., & Patterson, C. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.2962 · Cited by 40
Caspase substrates and neurodegenerative diseases
Bulat, N., & Widmann, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.007 · Cited by 42
N-Terminal Ubiquitination of Amyloidogenic Proteins Triggers Removal of Their Oligomers by the Proteasome Holoenzyme
Ye, Y., Klenerman, D., & Finley, D. J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.08.021 · Cited by 39
Temperature and toxic Tau in Alzheimer's disease: new insights
Carrettiero, D. C., Santiago, F. E., Motzko-Soares, A. C. P., & Almeida, M. C. (2015) · Temperature · doi:10.1080/23328940.2015.1096438 · Cited by 41
Tau Alternative Splicing and Frontotemporal Dementia
Kar, A. N., Kuo, D. C., He, R.-Q., Zhou, J., & Wu, J. Y. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000183082.76820.81 · Cited by 41
Chaperoning shape-shifting tau in disease
Ryder, B. D., Wydorski, P. M., Hou, Z., & Joachimiak, Ł. A. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.12.009 · Cited by 44
Exploration of Aberrant E3 Ligases Implicated in Alzheimer’s Disease and Development of Chemical Tools to Modulate Their Function
Potjewyd, F., & Axtman, A. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.768655 · Cited by 37
Intracellular Degradation of Misfolded Tau Protein Induced by Geldanamycin is Associated with Activation of Proteasome
Opattová, A., Filipčík, P., Cente, M., & Novák, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121072 · Cited by 41
Semisynthetic and Enzyme‐Mediated Conjugate Preparations Illuminate the Ubiquitination‐Dependent Aggregation of Tau Protein
Munari, F., Barracchia, C. G., Franchin, C., Parolini, F., Capaldi, S., Romeo, A., Bubacco, L., Assfalg, M., Arrigoni, G., & D’Onofrio, M. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201916756 · Cited by 39
Small heat shock protein 22 kDa can modulate the aggregation and liquid–liquid phase separation behavior of tau
Darling, A. L., Dahrendorff, J., Creodore, S. G., Dickey, C. A., Blair, L. J., & Uversky, V. N. (2021) · Protein Science · doi:10.1002/pro.4060 · Cited by 37
CHIP-mediated hyperubiquitylation of tau promotes its self-assembly into the insoluble tau filaments
Kim, J. H., Lee, J., Choi, W. H., Park, S., Park, S. H., Lee, J. H., Lim, S. M., Mun, J. Y., Cho, H., Han, D., et al. (2021) · Chemical Science · doi:10.1039/d1sc00586c · Cited by 37
Bending Tau into Shape: The Emerging Role of Peptidyl-Prolyl Isomerases in Tauopathies
Koren, J., Jinwal, U. K., Davey, Z. S., Kiray, J., Arulselvam, K., & Dickey, C. A. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8182-4 · Cited by 39
Failure of Ubiquitin Proteasome System: Risk for Neurodegenerative Diseases
Chen, Z., Geetha, T., & Babu, J. R. (2014) · Neurodegenerative Diseases · doi:10.1159/000367694 · Cited by 42
Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat
KLEIN, R., Dayton, R. D., LIN, W., & Dickson, D. W. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.001 · Cited by 39
Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models
Hannan, S. B., Dräger, N. M., Rasse, T. M., Voigt, A., & Jahn, T. R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13532 · Cited by 38
The propagation mechanisms of extracellular tau in Alzheimer’s disease
Wei, Y., Liu, M., & Wang, D. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10573-y · Cited by 40
Super-resolution imaging unveils the self-replication of tau aggregates upon seeding
Dimou, E., Katsinelos, T., Meisl, G., Tuck, B. J., Keeling, S., Smith, A. E., Hidari, E., Lam, J. Y. L., Burke, M., Lövestam, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112725 · Cited by 43
Role of Heat Shock Proteins in Glaucoma
Tsai, T., Grotegut, P., Reinehr, S., & Joachim, S. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205160 · Cited by 38
The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders
Domenico, F. D., & Lanzillotta, C. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.05.008 · Cited by 38
Differential gene expression profiles in the hippocampus of senescence-accelerated mouse
Cheng, X., Zhou, W., Zhang, Y., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.004 · Cited by 38
Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy
Sreenivasmurthy, S. G., Iyaswamy, A., Krishnamoorthi, S., Reddi, R. N., Kammala, A. K., Vasudevan, K., Senapati, S., Zhu, Z., Su, C.-F., Liu, J., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1030534 · Cited by 38
Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid
Ye, S., Wang, D., Xu, Y., Wang, C., Cao, L., Liu, Y., & Zhu, C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150486 · Cited by 38
Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease
Tiernan, C. T., Ginsberg, S. D., Guillozet-Bongaarts, A. L., Ward, S., He, B., Kanaan, N. M., Mufson, E. J., Binder, L. I., & Counts, S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.031 · Cited by 38
Tau exhibits unique seeding properties in globular glial tauopathy
Chung, D. C., Carlomagno, Y., Cook, C. N., Jansen‐West, K. R., Daughrity, L. M., Lewis‐Tuffin, L. J., Castanedes‐Casey, M., Deture, M. A., Dickson, D. W., & Petrucelli, L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0691-9 · Cited by 38
Self-citation
Two distinct classes of cochaperones compete for the EEVD motif in heat shock protein 70 to tune its chaperone activities
Johnson, O. T., Nadel, C. M., Carroll, E. C., Arhar, T., & Gestwicki, J. E. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101697 · Cited by 40
BAG‐1M is up‐regulated in hippocampus of Alzheimer’s disease patients and associates with tau and APP proteins
Elliott, E., Laufer, O., & Ginzburg, I. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06047.x · Cited by 38
Regulation of Ubiquitin-like with Plant Homeodomain and RING Finger Domain 1 (UHRF1) Protein Stability by Heat Shock Protein 90 Chaperone Machinery
Ding, G., Chen, P., Zhang, H., Huang, X., Zang, Y., Li, J., Li, J., & Wong, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.727214 · Cited by 37
Calcium dependent regulation of protein ubiquitination – Interplay between E3 ligases and calcium binding proteins
Mukherjee, R., Das, A., Chakrabarti, S., & Chakrabarti, O. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.03.001 · Cited by 36
Chaperone-mediated autophagy: Advances from bench to bedside
Li, W., Nie, T., Xu, H., Yang, J. H., Yang, Q., & Mao, Z. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.010 · Cited by 36
The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicityin Vivo
Prifti, E., Tsakiri, E. N., Vourkou, E., Stamatakis, G. M., Samiotaki, M. K., & Papanikolopoulou, K. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1920-20.2020 · Cited by 39
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
Gu, J., & Liu, F. (2020) · Current Medical Science · doi:10.1007/s11596-020-2282-1 · Cited by 41
Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice
Rodríguez‐Navarro, J. A., Gómez, A., Rodal, I., Perucho, J., Martínez, A., Furió, V., Ampuero, I., Casarejos, M. J., Solano, R. M., de Yébenes, J. G., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn210 · Cited by 37
The E3 Ubiquitin Ligase, CHIP/STUB1, Inhibits Aggregation of Phosphorylated Proteoforms of Microtubule-associated Protein Tau (MAPT)
Nadel, C. M., Thwin, A. C., Callahan, M., Lee, K., Connelly, E. J., Craik, C. S., Southworth, D. R., & Gestwicki, J. E. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168026 · Cited by 34
Ca2+/S100 Proteins Act as Upstream Regulators of the Chaperone-associated Ubiquitin Ligase CHIP (C Terminus of Hsc70-interacting Protein)
Shimamoto, S., Kubota, Y., Yamaguchi, F., Tokumitsu, H., & Kobayashi, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.436758 · Cited by 35
Protective Role of Capsaicin in Neurological Disorders: An Overview
Tyagi, S., Shekhar, N., & Thakur, A. K. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03549-5 · Cited by 37
The co-chaperone CHIP is induced in various stresses and confers protection to cells
Dikshit, P., & Jana, N. R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.018 · Cited by 34
Proteostasis in neurodegenerative diseases
Kinger, S., Jagtap, Y. A., Kumar, P., Choudhary, A., Prasad, A., Prajapati, V. K., Kumar, A., Mehta, G., & Mishra, A. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.002 · Cited by 34
Semisynthetic Modification of Tau Protein with Di-Ubiquitin Chains for Aggregation Studies
Munari, F., Barracchia, C. G., Parolini, F., Tira, R., Bubacco, L., Assfalg, M., & D’Onofrio, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124400 · Cited by 34
Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease
Carroll, T., Guha, S. K., Nehrke, K. W., & Johnson, G. V. W. (2021) · Biology · doi:10.3390/biology10101047 · Cited by 39
Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies
Vacchi, E., Lazzarini, E., Pinton, S., Chiaro, G., Disanto, G., Marchi, F., Robert, T., Staedler, C., Galati, S., Gobbi, C., et al. (2022) · Brain · doi:10.1093/brain/awac161 · Cited by 35
Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer's Disease
García‐Sierra, F., Jarero-Basulto, J. J., Krištofíková, Z., Majer, E., Binder, L. I., & Řı́pová, D. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00525.x · Cited by 36
Carboxy Terminus Heat Shock Protein 70 Interacting Protein Reduces Tau-Associated Degenerative Changes
Saidi, L.-J., Polydoro, M., Kay, K. R., Sanchez, L., Mandelkow, E., Hyman, B. T., & Spires‐Jones, T. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142094 · Cited by 34
The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
van Tijn, P., Hol, E. M., van Leeuwen, F. W., & Fischer, D. F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.001 · Cited by 35
Tau Clearance Mechanisms
Tang, M., Harrison, J., Deaton, C. A., & Johnson, G. V. W. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_5 · Cited by 31
Synphilin-1 isoforms in Parkinson’s disease: regulation by phosphorylation and ubiquitylation
Szargel, R., Rott, R., & Engelender, S. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7343-0 · Cited by 33
Stress proteins in Alzheimer's disease
Smith, R. C., Rosen, K. M., Pola, R., & Magrané, J. (2005) · International Journal of Hyperthermia · doi:10.1080/02656730500133165 · Cited by 33
Caspase-cleaved Tau-D421 is colocalized with the immunophilin FKBP52 in the autophagy-endolysosomal system of Alzheimer's disease neurons
Méduri, G., Guillemeau, K., Dounane, O., Sazdovitch, V., Duyckaerts, C. J., Chambraud, B., Baulieu, E. E., & Giustiniani, J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.017 · Cited by 33
Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension
Hu, J., Sha, W., Yuan, S., Wu, J., & Huang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915023 · Cited by 40
Ancient origin of animal U-box ubiquitin ligases
Marı́n, I. (2010) · BMC Evolutionary Biology · doi:10.1186/1471-2148-10-331 · Cited by 31
Ubiquitin proteasome system as a pharmacological target in neurodegeneration
Hol, E. M., Fischer, D. F., Ovaa, H., & Scheper, W. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.9.1337 · Cited by 31
Progressive Supranuclear Palsy and Corticobasal Degeneration
Coughlin, D. G., Dickson, D. W., Josephs, K. A., & Litvan, I. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_11 · Cited by 33
Screening strategies to identify HSP70 modulators to treat Alzheimer’s disease
Repalli, J., & Meruelo, D. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s72165 · Cited by 31
Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease
Pace, M. C., Xu, G. M., Fromholt, S., Howard, J. C., Crosby, K. W., Giasson, B. I., Lewis, J. M., & Borchelt, D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1895-y · Cited by 31
CHIP facilitates ubiquitination of inducible nitric oxide synthase and promotes its proteasomal degradation
Chen, L., Kong, X., Fu, J., Xu, Y., Fang, S., Hua, P., Luo, L., & Yin, Z. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.03.009 · Cited by 31
Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation
Benussi, L., Ghidoni, R., Paterlini, A., Nicosia, F. M., Alberici, A., Signorini, S. G., Barbiero, L., & Binetti, G. G. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.021 · Cited by 31
Transcellular Spreading of Tau in Tauopathies
Demaegd, K. C., Schymkowitz, J. W. H., & Rousseau, F. (2018) · ChemBioChem · doi:10.1002/cbic.201800288 · Cited by 32
Therapeutic Strategies for Restoring Tau HomeostasisPreprint
Young, Z. T., Mok, S., & Gestwicki, J. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024612 · Cited by 31
Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies
Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32
Phosphorylation of tau at a single residue inhibits binding to the E3 ubiquitin ligase, CHIP
Nadel, C. M., Pokhrel, S., Wucherer, K., Oehler, A., Thwin, A. C., Basu, K., Callahan, M. D., Southworth, D. R., Mordes, D. A., Craik, C. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52075-1 · Cited by 36
Human Liver Cytochrome P450 3A4 Ubiquitination
Wang, Y., Kim, S., Trnka, M. J., Liu, Y., Burlingame, A. L., & Correia, M. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.611525 · Cited by 30
Transcriptome profiling of Issatchenkia orientalis under ethanol stress
Miao, Y., Xiong, G., Li, R., Wu, Z., Zhang, X., & Weng, P. (2018) · AMB Express · doi:10.1186/s13568-018-0568-5 · Cited by 30
Blocking the Thiol at Cysteine-322 Destabilizes Tau Protein and Prevents Its Oligomer Formation
Chen, H., Liu, S., Li, S., Chen, J., Ni, J., & Liu, Q. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00003 · Cited by 30
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology
Kalyaanamoorthy, S., Opare, S. K. A., Xu, X., Ganesan, A., & Rao, P. P. N. (2024) · Current Alzheimer Research · doi:10.2174/0115672050301407240408033046 · Cited by 32
The autophagy adaptor TRIAD3A promotes tau fibrillation by nested phase separation
Zhou, J., Chuang, Y. ‘., Redding‐Ochoa, J., Zhang, R., Platero, A. J., Barrett, A., Troncoso, J. C., Worley, P. F., & Zhang, W. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01461-4 · Cited by 33
Protein misfolding, ER stress and chaperones: an approach to develop chaperone-based therapeutics for Alzheimer’s disease
Singh, R., Kaur, N., Dhingra, N., & Kaur, T. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2021.1968859 · Cited by 30
Involvement of endoplasmic reticulum stress in tauopathy
Sakagami, Y., Kudo, T., Tanimukai, H., Kanayama, D., Omi, T., Horiguchi, K., Okochi, M., Imaizumi, K., & Takeda, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.007 · Cited by 29
Potential synergy between tau aggregation inhibitors and tau chaperone modulators
Blair, L. J., Zhang, B., & Dickey, C. A. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt207 · Cited by 30
Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases
Kabir, M. T., Uddin, M. S., Abdeen, A., Ashraf, G. M., Perveen, A., Hafeez, A., Bin-Jumah, M. N., & Abdel‐Daim, M. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200618114924 · Cited by 29
The Last Tangle of Tau
Ding, H., & Johnson, G. V. W. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14413 · Cited by 29
The Hsp70 and Hsp40 Chaperones Influence Microtubule Stability inChlamydomonas
Silflow, C. D., Sun, X., Haas, N. A., et al. (2011) · Genetics · doi:10.1534/genetics.111.133587 · Cited by 28
Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain
Thirstrup, K., Sotty, F., Montezinho, L., Badolo, L., Thougaard, A., Kristjánsson, M., Jensen, T. N., Watson, S. P., & Nielsen, S. M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.028 · Cited by 29
Protein-protein interactions underlying the behavioral and psychological symptoms of dementia (BPSD) and Alzheimer’s disease
Mao, Y., Fisher, D. W., Yang, S., Keszycki, R. M., & Dong, H. (2020) · PLOS ONE · doi:10.1371/journal.pone.0226021 · Cited by 28
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins
Sirtori, R., Riva, C., Ferrarese, C., & Sala, G. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135272 · Cited by 28
Structural Basis for Chaperone‐Independent Ubiquitination of Tau Protein by Its E3 Ligase CHIP
Munari, F., Mollica, L., Valente, C., Parolini, F., Kachoie, E. A., Arrigoni, G., D’Onofrio, M., Capaldi, S., & Assfalg, M. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202112374 · Cited by 26
Neuroprotective effects of chaperone-mediated autophagy in neurodegenerative diseases
Jia, Q., Li, J., Guo, X., Li, Y., Wu, Y., Peng, Y., Fang, Z., & Zhang, X. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385848 · Cited by 29

Authors: Petrucelli, L.
Affiliations: Mayo Clinic in Florida (US)
Corresponding author: Petrucelli, L.
ORCID: Petrucelli, L.
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 2004-01-28
Volume: 13
Issue: 7
Pages: 703-714
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/ddh083
OpenAlex: W2168079270
Cited by: 723
References: 41
Citations by year: 2026: 29 · 2025: 36 · 2024: 32 · 2023: 32 · 2022: 37 · 2021: 37 · 2020: 36 · 2019: 25 · 2018: 35 · 2017: 31 · 2016: 31 · 2015: 38 · 2014: 34 · 2013: 28 · 2012: 31
FWCI: 10.76
Type: journal article
Language: en
Open access: closed
Locations: Human Molecular Genetics (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: National Institute of Neurological Disorders and Stroke (R01NS041816, R01-NS41816-01)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords: CHIP, HSP70, tau protein, ubiquitination, protein degradation, tau aggregation, molecular chaperones, ubiquitin ligase, geldanamycin, heat shock factor 1, tauopathy, Alzheimer's disease, Parkinson's disease, proteasome
MeSH terms: Heat Shock Transcription Factors, Animals, Cell Line, Detergents, DNA-Binding Proteins, Genetic Vectors, Humans, Immunohistochemistry, Lac Operon, Models, Genetic, Mutation, Nuclear Proteins, Protein Binding, Quinones, Subcellular Fractions, Transcription Factors, Transfection, Blotting, Western, Benzoquinones, tau Proteins, Molecular Chaperones, HSP70 Heat-Shock Proteins, Transgenes, COS Cells, Ubiquitin, Drosophila Proteins, Ubiquitin-Protein Ligases, Cell Line, Tumor, Lactams, Macrocyclic, Immunoprecipitation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks